Press Releases
|
April 24, 2013 | |
Gen9 Receives $21 Million Strategic Investment from Agilent Technologies
Agilent’s Equity Stake Will Accelerate Growth and Innovation at Company Pioneering Next-Generation Gene Synthesis
“We believe that Gen9 has the correct strategy, technology, team, and IP portfolio to complement Agilent’s innovations in oligo library synthesis and, working together, we will help realize the promise of synthetic biology.”
Neil Cook, vice president and director, Agilent Laboratories
|
November 14, 2012 | |
Gen9 Announces Winners of Inaugural G-Prize Contest
Awardees to receive custom designed DNA for ground-breaking projects that will propel the synthetic biology field forward
|
September 25, 2012 | |
Gen9 Expands Scientific Advisory Board to Advance Synthetic Biology
Members bring world-class expertise in synthetic biology and technological innovation
|
July 23, 2012 | |
Gen9 Sponsors Contest to Recognize Innovation in Synthetic Biology
Inaugural G-Prize winners will receive more than a million base pairs of custom designed DNA
|
July 11, 2012 | |
Gen9 Announces Appointment of Kevin Munnelly as President and CEO
Company expands senior leadership team as it ramps up commercial fabrication capacity for synthesized genes
|
In the News
|
Boston Herald | |
Cambridge DNA whisperers
by Marie Szaniszlo - April 25, 2013
Synthetic biology co. Gen9 in $21M deal
|
The Boston Globe | |
Gen9, a Cambridge gene synthesis firm, gets $21m investment from Agilent Technologies
by Chris Reidy - April 24, 2013
|
Xconomy | |
Gen9, Synthetic Biology Startup, Snags $21M from Agilent
by Luke Timmerman - April 24, 2013
|
Boston Business
Journal | |
Kraft Group-backed Gen9 gets $21M from Agilent
by Patricia Resende - April 24, 2013
|
Boston Herald | |
Gen9 lands $21M investment from Agilent Technologies
by Ira Kantor - April 24, 2013
|
GenomeWeb | |
Agilent Makes $21M Investment in Gen9
April 24, 2013
|
Genetic Engineering
& Biotechnology News | |
Agilent Takes $21M Stake in Gen9
April 24, 2013
|
Scientific American
Worldview | |
Letter to the Editor (pdf)
by Kevin Munnelly - 2013 issue
|
Genetic Engineering
& Biotechnology News | |
Next-Gen Gene Synthesis Opens a World of New Possibilities
A discussion with synthetic biology pioneers Drew Endy, George Church, and David Baker.
March 2013
|
Money Morning | |
The Next Profit Breakthrough: Synthetic Biology
by Michael A. Robinson - December 13, 2012
|
The Scientist | |
Top 10 Innovations 2012
December 1, 2012
"Brings the cost and speed of DNA synthesis down to the point where entire vectors can be designed and assembled from scratch. A critical component needed to make synthetic biology a reality."
|
The Seattle Times | |
UW's brave (and bright!) new lab for molecular engineering
by Katherine Long - September 4, 2012
"The UW works with a Massachusetts company, Gen9, that has come up with a process to make genes on a very large scale."
|
Boston Globe | |
Gen9 hopes to be the Intel of custom DNA
by Scott Kirsner - July 22, 2012
|
Xconomy | |
Stealthy Gen9 Rolls Out BioFab for Large-Scale Gene Manufacturing
by Arlene Weintraub - July 17, 2012
|
VentureWire | |
Gen9 Appoints New CEO, Plans Series C to Scale Up Synthetic Bio Operation
by Brian Gromley, Dow Jones & Company, Inc. - July 13, 2012
|
Upcoming Events
|
May 11-12, 2013 | |
Mammalian Synthetic Biology Workshop at MIT
Sponsor: Gen9
|
Past Events
|
January 21, 2013 | |
PEPTALK in Palm Springs, CA
Speaker: Joe Jacobson - Founder
|
January 14, 2013 | |
ICBE 2013 in Fort Lauderdale, FL
Speaker: George Church - Founder
|
November 14, 2012 | |
SynBioBeta Conference in Silicon Valley, CA
Speaker: Kevin Munnelly - CEO
|
Twitter
| |
|
|
Contact:
media@gen9bio.com
|
